Loading...
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
Sorafenib is the current standard treatment for advanced hepatocellular carcinoma (HCC), but its efficacy is modest with low response rates and short response duration. Predictive biomarkers for sorafenib efficacy are necessary. However, efforts to determine biomarkers for sorafenib have led only to...
Na minha lista:
| Udgivet i: | World J Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579880/ https://ncbi.nlm.nih.gov/pubmed/26420960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i36.10336 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|